INS and type 2 diabetes mellitus: IL‐22 has been shown to protect insulin-producing β-cells by suppressing endoplasmic reticulum stress and inflammation, restoring glucose homeostasis, preserving the integrity of the gut mucosal barrier, and improving endotoxemia and chronic inflammation in an obesity-induced T2DM mouse model [36,37].